False-positive results in the randomized controlled trial of mammographic screening from age 40 ("age" trial)

Cancer Epidemiology Biomarkers and Prevention

Volumn 19, Issue 11, 2010, Pages 2758-2764

  Johns, Louise E ^a   Moss, Sue M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER MORPHOLOGY; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FALSE POSITIVE RESULT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOCIAL STATUS;

ADULT; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING;

EID: 78549261131     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0623     Document Type: Article

References (31)

1. International Agency for Research on Cancer. Breast cancer screening. Lyon: IARC Press; 2002.
2. Mushlin AI, Kouides RW, Shapiro DE. Estimating the accuracy of screening mammography: a meta-analysis. Am J Prev Med 1998;14:143-53.
3. Bennett RL, Blanks RG, Patnick J, Moss SM. Results from the UK NHS Breast Screening Programme 2000-05. J Med Screen 2007;14:200-4.
4. Fracheboud J, de Koning HJ, Beemsterboer PM, et al. Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening. Int J Cancer 1998;75:694-8.
5. Brewer NT, Salz T, Lillie SE. Systematic review: the long-term effects of false-positive mammograms. Ann Intern Med 2007;146:502-10.
6. Aro AR, Pilvikki AS, van Elderen TM, van der PE, van der Kamp LJ. False-positive findings in mammography screening induces short-term distress - breast cancer-specific concern prevails longer. Eur J Cancer 2000;36:1089-97.
7. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years' follow-up: a randomised controlled trial. Lancet 2006;368:2053-60.
8. Moss S, Trial Steering Group. A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40. J Med Screen 1999;6:144-8.
9. Phillimore P, Beattie A, Townsend P. Widening inequality of health in northern England, 1981-91. BMJ 1994;308:1125-8.
10. Census Dissemination Unit, University of Manchester. Available from: http://cdu.mimas.ac.uk/related/deprivation.htm.
11. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE. Screening mammography inwomen 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 2007;146:516-26.
12. Ascunce N, del Moral A, Murillo A, et al. Early detection programme for breast cancer in Navarra, Spain. Eur J Cancer Prev 1994;3 Suppl 1:41-8.
13. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138:168-75.
14. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998;338:1089-96.
15. Lidbrink E, Elfving J, Frisell J, Jonsson E. Neglected aspects of false positive findings ofmammography in breast cancer screening: analysis of false positive cases from the Stockholm trial. BMJ 1996;312:273-6.
16. Banks E, Reeves G, Beral V, et al. Impact of use of hormone replacement therapy on false positive recall in the NHS breast screening programme: results from the Million Women Study. BMJ 2004;328:1291-2.
17. Gotzsche PC, Hartling OJ, Nielsen M, Brodersen J, Jorgensen KJ. Breast screening: the facts - or maybe not. BMJ 2009;338:b86.
18. Jorgensen KJ, Gotzsche PC. Who evaluates public health programmes? A review of the NHS Breast Screening Programme J R Soc Med 2010;103:14-20.
19. Njor SH, Olsen AH, Schwartz W, Vejborg I, Lynge E. Predicting the risk of a false-positive test for women following a mammography screening programme. J Med Screen 2007;14:94-7.
20. Hofvind S, Thoresen S, Tretli S. The cumulative risk of a false-positive recall in the Norwegian Breast Cancer Screening Program. Cancer 2004;101:1501-7.
21. Wallis M, Neilson F, Hogarth H, Whitaker C, Faulkner K. Cumulative attendance, assessment and cancer detection rate over four screening rounds in five English breast-screening programmes: a retrospective study. J Public Health (Oxf) 2007;29:275-80.
22. Christiansen CL, Wang F, Barton MB, et al. Predicting the cumulative risk of false-positive mammograms. J Natl Cancer Inst 2000;92:1657-66.
23. Brett J, Austoker J. Women who are recalled for further investigation for breast screening: psychological consequences 3 years after recall and factors affecting re-attendance. J Public Health Med 2001;23:292-300.
24. Currence BV, Pisano ED, Earp JA, et al. Does biopsy, aspiration or six-month follow-up of a false-positive mammogram reduce future screening or have large psychosocial effects? Acad Radiol 2003; 10:1257-66.
25. Lampic C, Thurfjell E, Sjoden PO. The influence of a false-positive mammogram on a woman's subsequent behaviour for detecting breast cancer. Eur J Cancer 2003;39:1730-7.
26. Pinckney RG, Geller BM, Burman M, Littenberg B. Effect of false-positive mammograms on return for subsequent screening mammography. Am J Med 2003;114:120-5.
27. McCann J, Stockton D, Godward S. Impact of false-positive mammography on subsequent screening attendance and risk of cancer. Breast Cancer Res 2002;4:R11.
28. Burman ML, Taplin SH, Herta DF, Elmore JG. Effect of false-positive mammograms on interval breast cancer screening in a health maintenance organization. Ann Intern Med 1999;131:1-6.
29. Banks E, Beral V, Cameron R, et al. Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res 2002;4:R1.
30. Maheswaran R, Pearson T, Jordan H, Black D. Socioeconomic deprivation, travel distance, location of service, and uptake of breast cancer screening in North Derbyshire, UK. J Epidemiol Community Health 2006;60:208-12.
31. Johns LE, Moss SM. Randomized controlled trial of mammographic screening from age 40 ("Age" trial): patterns of screening attendance. J Med Screen 2010;17:37-43.